52-Week high Stocks are MYL, PLX, OSK by Super Hot Penny Stocks
52-Week high
Dallas, TX 11/05/2009 06:10 PM GMT (TransWorldNews)
Subscribe to Free Stock Alerts and Free Newsletter by visiting: http://www.SuperHotPennyStocks.com
Mylan Inc. (NASDAQ:MYL) after yesterday’s new 52 high today again made a new 52-week high at $17.26 and now up 2.19% to $17.23 Mylan Inc. (Mylan) and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients (API). As of May 5, 2009, the Company held a 71.2% interest in Matrix Laboratories Limited (Matrix).
Protalix BioTherapeutics Inc. (AMEX:PLX) crossed its earlier 52-week highs and today made a new high at $11.70. The stock is up 4.86% at $11.22. Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system.
Oshkosh Corporation (NYSE:OSK) jumped 3.44% to $36.95. Today the stock made a new 52-week high of $37.19. Oshkosh Corp. is a designer, manufacturer and marketer of a range of specialty vehicles and vehicle bodies. The Company operates in four segments: access equipment, defense, fire & emergency, and commercial.
ABOUT http://www.SuperHotPennyStocks.com
SuperHotPennyStocks.com is a leading Stock Trading News Alert website which offers free Stock News Alerts and Newsletter to investors. We track various stocks, small cap, and penny stocks that are on the brink of making big gains. If you would like to feature your company on our website then does contact us at info@ SuperHotPennyStocks.com
info[@]SuperHotPennyStocks.com
www.SuperHotPennyStocks.com
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
MYL
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
